Together with the Alzheimer’s Association, Brain Canada is funding five research teams to develop preliminary data and apply knowledge to the fields of Alzheimer’s and all dementias.
In partnership with the Alzheimer’s Association, Brain Canada is pleased to award five grants to Canadian-led teams who are advancing our understanding of Alzheimer's disease, helping to identify new treatment strategies, providing information to improve care for people with dementia, and furthering our knowledge of brain health and disease prevention through the Alzheimer’s Association International Research Grant Program.
“This funding allows researchers to engage at the international level and contribute to research on Alzheimer’s disease and dementias. Brain Canada is proud to partner on programs that reward excellent research around the globe and lead to advances for people living with Alzheimer’s and dementias and their families,” says Dr. Viviane Poupon, President, and CEO of Brain Canada. “The IRGP projects align with our mission to better understand the brain in health and in illness and their learnings can be applied to a range of brain disorders and diseases amplifying the impact of this investment.”
The IRGP consists of eight grant competitions for new investigators, including those with unique expertise, alongside exceptional post-graduate researchers and scientists. The projects funded by Brain Canada include:
Alzheimer’s Association Research Grant - New to the Field (AARG-NTF)
- Electrophysiological measures of proteinopathy in asymptomatic older adults. $190,677 CAD awarded to Sylvain Baillet, PhD, The Montreal Neurological Institute-Hospital
Alzheimer’s Association Research Grant (AARG)
- Detecting Behaviours of Risk in Nursing Homes using Deep Learning. $190,788 CAD awarded to Shehroz Khan, PhD, University Health Network
- Serotonin circuit dysregulation in Alzheimer’s Disease. $190,780 CAD awarded to Derya Sargin, PhD, University of Calgary
- Cholinergic & noradrenergic contributions to presymptomatic AD progression. $188,892 CAD awarded to Nathan Spreng, PhD, The Montreal Neurological Institute-Hospital
Alzheimer’s Association Research Fellowship (AARF)
- From Space to Memory Under Pathological Tau. $197,160 CAD awarded to James Carmichael, PhD, Douglas Hospital Research Center
These Canadian-based IRGP projects have been made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and Brain Canada, and by the Alzheimer’s Association. To date, Health Canada has invested over $130 million through the CBRF which has been matched by Brain Canada Foundation and its donors and partners.